Your Source for Venture Capital and Private Equity Financings

Benchling Bags $100M Series F

2021-11-21
SAN FRANCISCO, CA, Benchling, an R&D Cloud biotechnology startup, has raised $100 million in Series F funding co-led by Franklin Templeton and Altimeter Capital.
Benchling, an R&D Cloud biotechnology startup, has raised $100 million in Series F funding at a $6.1 billion valuation. The round was co-led by new investor Franklin Templeton and existing investor Altimeter Capital, and joined by new investors Tiger Global and Lone Pine Capital, as well as existing investors.

Benchling is the leader in cloud-based informatics for life science R&D. The company offers a unified R&D platform purpose-built for biologics, including solutions for Lab Notebook, Molecular Biology, Bioregistration, Sample Tracking, and Request & Workflow Management. Benchling is used by over 100,000 scientists globally throughout multinational pharmaceutical corporations, emerging biotechnology companies, and major research institutions.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors